These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27536130)
1. Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer. Sun X; Wang J; Liu J; Chen S; Liu X Onco Targets Ther; 2016; 9():4661-9. PubMed ID: 27536130 [TBL] [Abstract][Full Text] [Related]
2. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
3. Impact of serum albumin concentration and neutrophil-lymphocyte ratio score on gastric cancer prognosis. Costa T; Nogueiro J; Ribeiro D; Viegas P; Santos-Sousa H Langenbecks Arch Surg; 2023 Jan; 408(1):57. PubMed ID: 36689025 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up. Jin H; Sun J; Zhu K; Liu X; Zhang Q; Shen Q; Gao Y; Yu J Onco Targets Ther; 2017; 10():2655-2664. PubMed ID: 28579803 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer. Wang H; Ding Y; Li N; Wu L; Gao Y; Xiao C; Jiang H; Zheng Y; Mao C; Deng J; Wang H; Xu N Front Oncol; 2020; 10():841. PubMed ID: 32637353 [No Abstract] [Full Text] [Related]
6. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer. Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885 [TBL] [Abstract][Full Text] [Related]
7. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536 [TBL] [Abstract][Full Text] [Related]
8. Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer. Weng J; Huang J; Yu W; Zhao Z; Zhu B; Lin J; Cai Y; Zhang J; Su W; Chen X; Zhu K; Lin S J Thorac Dis; 2021 Sep; 13(9):5508-5516. PubMed ID: 34659817 [TBL] [Abstract][Full Text] [Related]
9. A cumulative score based on preoperative fibrinogen and the neutrophil-lymphocyte ratio to predict outcomes in resectable gastric cancer. Liu X; Liu Z; Lin E; Chen Y; Sun X; Zhou Z Cancer Manag Res; 2018; 10():3007-3014. PubMed ID: 30214295 [TBL] [Abstract][Full Text] [Related]
10. Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after Gastrectomy. Onuma S; Hashimoto I; Suematsu H; Nagasawa S; Kanematsu K; Aoyama T; Yamada T; Rino Y; Ogata T; Oshima T J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983614 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the combination of preoperative fibrinogen and the neutrophil-lymphocyte ratio in patients with non-small cell lung cancer following surgical resection. Liang HG; Gao K; Jia R; Li J; Wang C Oncol Lett; 2019 Feb; 17(2):1435-1444. PubMed ID: 30675197 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Mao M; Wei X; Sheng H; Chi P; Liu Y; Huang X; Xiang Y; Zhu Q; Xing S; Liu W Oncol Lett; 2017 Dec; 14(6):7417-7424. PubMed ID: 29344182 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection. Zhou B; Zhan C; Xiang J; Ding Y; Yan S BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651 [TBL] [Abstract][Full Text] [Related]
14. Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer. Liu X; Sun X; Liu J; Kong P; Chen S; Zhan Y; Xu D Transl Oncol; 2015 Aug; 8(4):339-45. PubMed ID: 26310380 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer. Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863 [TBL] [Abstract][Full Text] [Related]
16. Novel immunological and nutritional-based prognostic index for gastric cancer. Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461 [TBL] [Abstract][Full Text] [Related]
17. Impact of systemic inflammation on gastric cancer outcomes. Liu X; Chen S; Liu J; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X PLoS One; 2017; 12(3):e0174085. PubMed ID: 28358923 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Pan QX; Su ZJ; Zhang JH; Wang CR; Ke SY Onco Targets Ther; 2015; 8():1375-85. PubMed ID: 26124667 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]